This inventor holds 1 USPTO granted patent. Top assignee: Sichuan Keiun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Wenjia Li and a Patent on 4′-Thionucleoside Compounds.
Introduction
Wenjia Li is an inventor associated with Sichuan, China, and Sichuan Keiun-Biotech Biopharmaceutical Co., Ltd. The supplied information identifies her as a woman and credits her with 1 patent.
Latest Patents
Li is named on the patent “Compound of 4′-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof.” The invention concerns a phosphamide derivative of 4′-thionucleoside, its preparation, and pharmaceutical compositions containing it. The patent describes potential applications in medicines intended to prevent or treat abnormal cell proliferation diseases, including tumors and cancers, as well as viral infectious diseases.
Career Highlights
The patent reflects Li’s work in biopharmaceutical research and development, particularly in compounds with potential therapeutic applications. The supplied information associates her with Sichuan Keiun-Biotech Biopharmaceutical Co., Ltd.
Collaborations
Gang Liu and Donghong Li are identified as Li’s coworkers. Their names also appear in the context of her patent-related work.
Conclusion
Wenjia Li’s recorded patent focuses on a 4′-thionucleoside derivative and its potential pharmaceutical uses, highlighting her contribution to biopharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile